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Establishing  a symptom–rhythm  correlation  in patients  with  unexplained  syncope  is  complicated
because  of  its sporadic,  infrequent,  and  unpredictable  nature.
Recently, an  implantable  loop  recorder  (ILR)  has  become  available  to evaluate  undiagnosed  recur-
rent  arrhythmic  episodes  particularly  in  unexplained  syncopes,  and  its  usefulness  has  been  reported  in
patients  with  recurrent  syncopes  that  remain  unexplained  after  conventional  work-up.
A  65-year-old  man  was  referred  to our  hospital  for  loss  of  consciousness  with  nocturnal  paroxys-
mal  seizures.  He  had  experienced  several  similar  episodes.  No  family  history  of  sudden  death  was
evident,  and  apparent  structural  heart  disease  was  absent.  Coronary  angiography  with  intracoronary
ergonovine  provocation  showed  vasospasm  in left coronary  artery  without  organic  stenosis.  Ventricular
tachyarrhythmias  were  not  induced  by programmed  electrical  stimuli.  According  to  the guideline,  he was
at  once  categorized  as  having  class  IIb  indication  for implantable  cardioverter  deﬁbrillator  implantation.
However,  his  symptoms  were  not  relieved  despite  administration  of  anti-anginal  medications  includ-
ing  nitrates  and  calcium  antagonist.  Implantation  of  an  ILR was performed  and  revealed  an  episode
of  ventricular  ﬁbrillation  during  generalized-convulsion  attack  during  sleep.  ILR  is useful  in  determin-
ing  the  presence  of  fatal  arrhythmias  during  syncope,  although  conventional  diagnostic  testing,  such as
electrocardiogram,  Holter  monitoring,  and  external  loop  recording,  is inconclusive.
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A  60-year-old male suffered from recurrent episodes of noctur-
al paroxysmal convulsion and was admitted to our hospital. His
ttacks were accompanied with or without generalized convulsion
ince the previous three years. The frequency of attacks was  twice
r three times per year, mostly at mid-night hours during sleep. His
2-lead electrocardiogram (ECG) showed sinus rhythm with a heart
ate of 48 bpm, a PR interval of 180 ms,  a QRS duration of 100 ms,  a
orrected QT interval of 410 ms,  and saddleback type ST-elevation
ith a J-wave amplitude > 2 mm in lead V2 (Fig. 1A). J wave was
lso observed in the inferolateral lead. After placement of the
ight precordial leads in superior positions, ECGs revealed coved-
ype ST elevation with a J-wave amplitude > 2 mm in leads V1–2
Fig. 1B). Holter ECG monitoring revealed only frequent, unifocal
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ttp://dx.doi.org/10.1016/j.jccase.2012.06.003ventricular premature contractions. Echocardiography, brain elec-
troencephalography, and magnetic resonance imaging of central
nervous system revealed negative ﬁndings. Coronary angiography
demonstrated no signiﬁcant stenotic lesions with vasospasm by
ergonovine provocation test (Fig. 2). Cardiac electrophysiologic
study (EPS) failed to induce ventricular tachycardia (VT) or ven-
tricular ﬁbrillation (VF) by up to three extra-stimuli coupling at
two drive cycle lengths at right ventricular apex and outﬂow tract
before and after isoproterenol infusion. Although this patient had
undergone extensive evaluation, no arrhythmic events had been
uncovered. Molecular genetic analysis was  not performed. Based on
these ﬁndings, the indication of implantable cardioverter deﬁbrilla-
tor (ICD) implantation was class IIb according to the Guidelines for
Non-Pharmacological Therapy of Cardiac Arrhythmias (published
from Japanese Circulation Society 2011) [1], and he was treated
as an out-patient. In order to clarify the exact cause of syncope,
he received implantation of an implantable loop recorder (ILR).
One month later following ILR implantation, his wife reported a
generalized-convulsion attack during sleep. Telemetry reading of
vier Ltd. All rights reserved.
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Fig. 1. The electrocardiogram on admission (A). After placement of right precordial leads in superior positions (B).
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aFig. 2. Coronary angiography: (A) left coronary angiogram in the right anterior 
he ILR revealed an episode of VF (Fig. 3). In addition, a positive
-wave deﬂection inscribed on the S wave emerged before VF occur-
ence and disappeared after VF termination by the record of ILR
Fig. 4).
Subsequently, an ICD was implanted to manage the VF. To date,
o more VT nor VF or any therapeutic shock was recorded by the
ackup ICD.
iscussion
In  this case, although recurrence of nocturnal syncope was
bserved, however, VF or VT with hemodynamic compromise was
ot induced by EPS, so ICD implantation was not initially indicated
ccording to the guidelines for non-pharmacotherapy of cardiac
rrhythmia published by the Japanese Circulation Society with the
pplicability criterion of class IIb [1]. An ILR was implanted fore caudal view and (B) right coronary angiogram in the left anterior oblique 40◦ .
follow-up  scrutiny, and consequently ICD implantation was  deter-
mined by record of spontaneous VF episode. The documentation
of fatal arrhythmia by ILR offered decisive evidence for the ICD
implantation.
The prognosis of Brugada syndrome (BS) [2] varies depending
on reports [3–7], and there are no clear standards with regard to
what kind of management should be performed in patients with
applicability of class IIb for ICD implantation as in our case. To date,
the decisions are entrusted to the clinician’s arbitrary judgment.
The  management of patients with symptomatic BS slightly dif-
fer between Europe and the USA and Japan. In Europe and the USA,
the patient is determined as being suitable for ICD implantation if
they have both a coved-type Brugada ECG and history of syncope. In
addition, according to the second consensus report regarding BS [8],
if a patient has a spontaneous type 1 ECG (coved-type ST increase
of 2 mm or more electrical potential at J point) with a history of
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Fig. 3. Implanted loop recorder revealed ventricular ﬁbrillation episodes twice: (A) 1st event (sustained for 60 s) and (B) 2nd event (sustained for 96 s).
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nd  E) after ﬁrst event (D) and second event (E). ST-segment was  elevated before ﬁ
ust before episode of ventricular ﬁbrillation (VF) (black arrows), which disappeare
yncope, there is ICD implant applicability of class I when extracar-
iac factors are excluded. In addition, patients that exhibit a type 1
CG after the administration of a Na channel blocker are indicated
or ICD implantation with applicability of class IIa if there is a history
f syncope and when extracardiac factors are excluded. There-
ore, the presence of a syncopal episode is emphasized regarding
ndication for ICD implantation in western countries. The multi-
nstitutional research by Eckardt et al. [6] and the report by
iustetto et al. [7] demonstrated that the incidence of cardiovas-
ular events in patients with a history of syncope was signiﬁcantly
igh as compared to the asymptomatic cases with incidence of 6.2%
nd 8.6%, respectively.
In  Japan, the presence of VF induction in electrophysiological
est  is the major clinical factor with regard to ICD implantation
ccording to the Japanese guideline. The cardiovascular contract
esearch by the Ministry of Health, Labor and Welfare as well as J-
VF research [9] by the Idiopathic Ventricular Fibrillation Research
ociety have been carried out as a prospective investigation on the
rognosis of BS since 2001 in Japan. The annual incidence of cardio-
ascular events in patients with a history of VF and cardiac arrest
as found to be similar in the reports from the USA and Europe,
owever, the prognosis of the patients’ group with a history of
yncope was better than those in the western countries.
The indication of ICD implantation in patients with coved-type
rugada ECG without the induction of polymorphic ventricular
achycardia or VF by EPS is determined as class IIb even if there is
 history of syncope. Regarding patients with no active application
f ICD implantation, the family history, the presence of mutation
f the myocardial Na channel (SCN5A) and the presence of latee electrocardiogram (ECG); (B and C) before ﬁrst event (B) and second event (C); (D
 second event as compared with baseline ECG. In addition, J-wave notch appeared
ediately after the termination of VF episode.
potential-positive ﬁndings are used as references in considering the
applicability of ICD implantation, and a careful follow-up is carried
out when implantation is not performed.
In recent years, ILR has been reported to be useful for the diagno-
sis of syncope, with a signiﬁcantly higher diagnostic rate than other
conventional tests. The Randomized Assessment of Syncope Trial
(RAST) [10] was  the ﬁrst trial for idiopathic syncope with ILR. In
this trial, 60 patients with idiopathic syncope and no abnormalities
upon orthostatic blood pressure testing, Holter electrocardiogra-
phy, and echocardiogram were randomly assigned to 30 cases of
a conventional test group that underwent external loop recorder,
tilt test, and electrophysiological testing, along with 30 cases of an
ILR group. Each group was followed up for 12 months and crossed-
over between both groups when a diagnosis could not be made. The
results demonstrated that the diagnosis was  obtained with 52% for
the ILR group in comparison with 20% for the conventional group.
Following cross-over, ILR was more likely to result in an accurate
diagnosis than conventional testing.
In this case, ILR revealed two episodes of VF both approxi-
mately 1 min  in duration with spontaneous termination, and 2 mm
elevation of the ST-segment with coved-type conﬁguration was
observed before an episode of VF which was not observed in
baseline ECG. Baseline 12-lead ECG demonstrated the early repo-
larization in not only precordial leads but also inferolateral leads.
Kamakura et al. [11] documented that Brugada-pattern ST eleva-
tion with inferolateral early repolarization was  an indicator of poor
prognosis and may  represent electric heterogeneity in extensive
regions of ventricles, which can result in ventricular arrhythmias.
Furthermore, positive J wave deﬂection inscribed on the S wave
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merged just before VF occurrence and disappeared after the ter-
ination of VF on the record of ILR in our case (Fig. 4). Sorgente et al.
12] reported the case of a patient with Brugada syndrome, in whom
arly repolarization in the inferolateral leads disappeared after a VF
pisode. They also demonstrated that 12-lead ECG obtained after
F termination revealed disappearance of J wave in inferolateral
eads. These reports and our case may  suggest the etiological asso-
iation between the presence of early repolarization abnormalities
nd VF occurrence.
ICD  implantation was performed in the present case on the basis
f VF documentation by ILR. In this case, although there was  a his-
ory of syncope, a family history of sudden death or the results
f conventional test were negative, so the patient was initially
lassiﬁed as IIb indication for ICD implantation. ILR was  useful for
etecting spontaneous episodes of lethal ventricular tachyarrhyth-
ia. Our case suggests that ILR implantation can provide additional
iagnostic information in patients with BS whose applicability for
CD implantation is not conclusive by conventional tests.
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